International Myeloma Society

Analysis

International Myeloma Society is a registered charity in United States, based in United Kingdom. It received its IRS tax-exemption ruling in May 2009, 17 years ago. Its declared purposes cover medical research, which this site groups under health and saving lives. The IRS classifies it as a publicly supported organisation (gross receipts test) under section 501(c)(3), and contributions to it are listed as tax-deductible.

In the financial year ending December 2023, International Myeloma Society reported income of $11.4m and spending of $9.4m, spending 83% of its income. Across the 5 years on record, from December 2019 to December 2023, income grew from $4.3m to $11.4m (+168%), an average of +28% a year. The sharpest change came in the year to December 2023, when income rose by 219%. Over the whole period it spent 67% of the income it received.

Among 40,470 United States charities whose main cause is health and saving lives and that reported income, International Myeloma Society sits at the 85th percentile: it is larger than about 85% of them. Against every charity in United States with reported income it ranks in the 95th percentile. Charities of a similar size with the same main cause include United Health Services Inc ($11.4m), National Kidney Foundation Inc ($11.4m) and High Plains Community Health Center Incorporated ($11.4m).

On its Form 990 for the period ending December 2023, revenue came from contributions and grants 100% of the total. Other salaries and wages came to $67k. At year end it held assets of $8.8m against liabilities of $79k, net assets of $8.7m. It reported 1 employees.